CARLSBAD, Calif., Oct. 22, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, will attend the CIBC World Markets 18th Annual Healthcare Conference. Dirk Kuyper, President and Chief Executive Officer of Alphatec, is scheduled to present at 4:15 p.m. EST on Monday, November 5, 2007, at the Waldorf-Astoria Hotel in New York City.
The company's presentation will be available to the public via audio webcast from the investor relations section of the Company's corporate Web site at www.alphatecspine.com. The webcast will be recorded and will remain available on the investor relations section of Alphatec's website, www.alphatecspine.com, for two weeks thereafter.
To learn more about the conference, please contact Ashley M. Sprague at 212.667.7135 or ashley.sprague@us.cibc.com.
About Alphatec
Alphatec Holdings, Inc. (Nasdaq:ATEC) designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Alphatec's broad product portfolio and pipeline includes a variety of spinal implant products and systems focused on solutions addressing the cervical, thoracolumbar, intervertebral, minimally invasive, motion preservation, vertebral compression fractures and allograft markets. Alphatec's "surgeons' culture" emphasizes collaboration with spinal surgeons to conceptualize, design and co-develop a broad range of products. State-of-the-art in-house manufacturing capabilities provide a unique competitive advantage, enabling Alphatec to rapidly deliver customized solutions to meet surgeons' and patients' critical needs. Alphatec has 22 issued U.S. patents, six issued foreign patents and 21 pending patent applications, including 10 pending U.S. applications, six pending international applications and five pending foreign national applications. Alphatec's principal product offerings are primarily focused on the global spine fusion market, which is estimated by Alphatec to be more than $5.9 billion in 2007. In addition to its U.S. operations, Alphatec also markets a range of spine and orthopedic products in Japan through its subsidiary, Alphatec Pacific, Inc. For more information, please visit www.alphatecspine.com.
The Alphatec Holdings, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3520